Read + Share
Amedeo Smart
Independent Medical Education
Li J, Ding F, Zhang S, Jia Y, et al. Continuation of same programmed death-1 inhibitor regime beyond progression is a novel option for advanced gastric cancer. BMC Cancer 2024;24:1292.PMID: 39425079
Email
LinkedIn
Privacy Policy